Literature DB >> 25547482

Relationship of the urine cortisol level with the performance status of patients with lung cancer: a retrospective study.

Kensuke Suzuki1, Tomomi Ichikawa, Hideaki Furuse, Takeshi Tsuda, Kotaro Tokui, Yasuaki Masaki, Seisuke Okazawa, Kenta Kambara, Minehiko Inomata, Toru Yamada, Toshiro Miwa, Shoko Matsui, Tatsuhiko Kashii, Hirokazu Taniguchi, Ryuji Hayashi, Kazuyuki Tobe.   

Abstract

PURPOSE: Cortisol plays an important role in the physical status of patients with end-stage lung cancer, but the association of urine cortisol levels with TNM stage/performance status (PS) is unclear in patients with advanced lung cancer receiving chemotherapy. The objective of this study was to examine this association.
METHODS: In this single-center, retrospective, observational study, cortisol concentrations in 24-h pooled urine from 22 patients with advanced lung cancer were measured over 2 days. The mean concentration in each patient was compared with PS, TNM stage, and serum sodium and potassium ion levels.
RESULTS: The 24-h urine cortisol levels were higher in PS2 or PS3 cases compared to PS1 (p < 0.05) and increased proportionally with PS. Urine cortisol also increased in N2 or N3 cases compared to N1 (p < 0.01) and also increased in M1 cases (p < 0.05). Urine cortisol levels were negatively correlated with serum sodium (R = -0.49, p < 0.05) and had a tendency for a positive correlation with serum potassium (R = 0.40, p = 0.06).
CONCLUSION: The 24-h urine cortisol level increased in patients with advanced lung cancer undergoing chemotherapy. Low serum levels of potassium and high levels of sodium may indicate relative adrenal insufficiency.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25547482     DOI: 10.1007/s00520-014-2585-5

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  11 in total

Review 1.  Cortisol levels and adrenal response in severe community-acquired pneumonia: a systematic review of the literature.

Authors:  Jorge I F Salluh; Cássia Righy Shinotsuka; Márcio Soares; Fernando A Bozza; José Roberto Lapa e Silva; Bernardo Rangel Tura; Patrícia T Bozza; Carolina Garcia Vidal
Journal:  J Crit Care       Date:  2010-09       Impact factor: 3.425

Review 2.  Antiinflammatory action of glucocorticoids--new mechanisms for old drugs.

Authors:  Turk Rhen; John A Cidlowski
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245

3.  Impact of sleep debt on metabolic and endocrine function.

Authors:  K Spiegel; R Leproult; E Van Cauter
Journal:  Lancet       Date:  1999-10-23       Impact factor: 79.321

4.  Increased urinary excretion of cortisol and catecholami-NES in malnourished cancer patients.

Authors:  C Drott; G Svaninger; K Lundholm
Journal:  Ann Surg       Date:  1988-11       Impact factor: 12.969

5.  Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings.

Authors:  D L Musselman; A H Miller; M R Porter; A Manatunga; F Gao; S Penna; B D Pearce; J Landry; S Glover; J S McDaniel; C B Nemeroff
Journal:  Am J Psychiatry       Date:  2001-08       Impact factor: 18.112

6.  A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin.

Authors:  D Annane; V Sébille; G Troché; J C Raphaël; P Gajdos; E Bellissant
Journal:  JAMA       Date:  2000-02-23       Impact factor: 56.272

Review 7.  Neuroendocrine-immune mechanisms of behavioral comorbidities in patients with cancer.

Authors:  Andrew H Miller; Sonia Ancoli-Israel; Julienne E Bower; Lucile Capuron; Michael R Irwin
Journal:  J Clin Oncol       Date:  2008-02-20       Impact factor: 44.544

8.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

9.  Adrenal response in severe community-acquired pneumonia: impact on outcomes and disease severity.

Authors:  Jorge I F Salluh; Fernando A Bozza; Márcio Soares; Juan Carlos R Verdeal; Hugo C Castro-Faria-Neto; José Roberto Lapa E Silva; Patrícia T Bozza
Journal:  Chest       Date:  2008-08-27       Impact factor: 9.410

10.  Reduced total energy expenditure and physical activity in cachectic patients with pancreatic cancer can be modulated by an energy and protein dense oral supplement enriched with n-3 fatty acids.

Authors:  A W G Moses; C Slater; T Preston; M D Barber; K C H Fearon
Journal:  Br J Cancer       Date:  2004-03-08       Impact factor: 7.640

View more
  2 in total

1.  Fenofibrate prevents skeletal muscle loss in mice with lung cancer.

Authors:  Marcus D Goncalves; Seo-Kyoung Hwang; Chantal Pauli; Charles J Murphy; Zhe Cheng; Benjamin D Hopkins; David Wu; Ryan M Loughran; Brooke M Emerling; Guoan Zhang; Douglas T Fearon; Lewis C Cantley
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-08       Impact factor: 11.205

2.  Psychoneuroendocrinological effects of music therapy versus mindfulness in palliative care: results from the 'Song of Life' randomized controlled trial.

Authors:  Friederike Koehler; Jens Kessler; Martin Stoffel; Martin Weber; Hubert J Bardenheuer; Beate Ditzen; Marco Warth
Journal:  Support Care Cancer       Date:  2021-08-06       Impact factor: 3.603

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.